Anticipation Grows for Theratechnologies Financial Announcement
Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX) is known for its commitment to developing innovative biopharmaceutical therapies. As a company that aims to redefine standards of care, the excitement is palpable as it prepares to share critical financial results and contemporaneous business updates.
Details of the Upcoming Financial Report
Theratechnologies will release its financial results for the fourth quarter and the entire fiscal year 2024, which ended on November 30. This significant update is scheduled for a live announcement, allowing stakeholders to gain insight into the Company's performance.
Key Announcement Date and Time
The live conference call will take place at 8:30 a.m. ET on February 26, 2025. Theratechnologies encourages all interested parties to join the call approximately ten minutes early to ensure they can access the session seamlessly.
Management Team Participation
This forthcoming discussion will be led by Paul Lévesque, the President and Chief Executive Officer, supported by other key executives such as Philippe Dubuc, Senior Vice President and Chief Financial Officer, and Christian Marsolais, Ph.D., Senior Vice President and Chief Medical Officer. Such an experienced team is set to provide clarity and specific insights into the company’s strategic vision moving forward.
How to Participate in the Conference Call
To partake in this important financial discussion, stakeholders can dial the following numbers:
- Toll-Free: 1-888-513-4119
- International: 1-412-902-6615
For those who cannot join the call live, a replay of the conversation will be available, enabling interested parties to hear the detailed discourse at their convenience.
Future Guidance and Strategic Insights
During the call, Theratechnologies is expected to share its outlook for the coming fiscal year, providing insights into ongoing projects and anticipated advancements in their therapeutic offerings. By continuously innovating and focusing on patient-centric approaches, the company aims to meet the evolving demands of the healthcare landscape.
About Theratechnologies
Established as a leader in specialty biopharmaceuticals, Theratechnologies is distinguished by its dedication to enhancing patient care through innovative solutions. The Company’s portfolio includes products designed to treat unmet medical needs, reinforcing its commitment to patient health and wellbeing.
Frequently Asked Questions
When will Theratechnologies announce its financial results?
Theratechnologies will announce its results on February 26, 2025, at 8:30 a.m. ET.
Who will be leading the conference call?
Paul Lévesque, the President and CEO, will lead the conference call, joined by other senior executives.
How can I access the call if I miss it live?
A replay will be available for those who cannot participate in the live discussion.
What are the key focus areas for Theratechnologies?
The Company remains focused on developing innovative therapies that address significant medical needs.
Where can I find more information about Theratechnologies?
Additional information is available on Theratechnologies' official website and various financial reporting platforms.
